发明名称 Integrin linked kinase modulation of macrophage activation
摘要 Methods are provided to specifically modulate the activation of monocytes and/or macrophages. Administration of integrin linked kinase (ILK) blocking agents; compounds that otherwise prevent the binding of natural ILK ligands to ILK; or compounds that prevent expression of, or signaling through ILK exert an anti-inflammatory effect by inhibiting iNOS and COX-2 expression, at the level of transcription by suppressing the activation of NF-kappaB. The modulation of activation through ILK is used to regulate immune processes at targeted sites, for example to decrease undesirable inflammatory responses.
申请公布号 US2005220779(A1) 申请公布日期 2005.10.06
申请号 US20020163599 申请日期 2002.06.05
申请人 KOJIC LJILJANA;LOGAN PATRICIA M;WHEELER JEFFERY J;SUTTON KYMBERLEY L;KALMAR GABRIEL B 发明人 KOJIC LJILJANA;LOGAN PATRICIA M.;WHEELER JEFFERY J.;SUTTON KYMBERLEY L.;KALMAR GABRIEL B.
分类号 A61K31/00;A61K31/415;A61K31/44;A61K38/45;C12N9/12;(IPC1-7):A61K38/45 主分类号 A61K31/00
代理机构 代理人
主权项
地址